Doximity (DOCS)
NYSE:DOCS
US Market
Holding DOCS?
Track your performance easily

Doximity (DOCS) Technical Analysis

558 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Doximity’s (DOCS) Moving Averages Convergence Divergence (MACD) indicator is 1.78, suggesting Doximity is a Buy.
Doximity’s (DOCS) 20-Day exponential moving average is 42.06, while Doximity’s (DOCS) share price is $43.31, making it a Buy.
Doximity’s (DOCS) 50-Day exponential moving average is 38.39, while Doximity’s (DOCS) share price is $43.31, making it a Buy.

Doximity (DOCS) Pivot Points

Oct 13, 2024, 10:46 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
41.93
42.48
42.92
43.47
43.90
44.45
44.89
Fibonacci
42.48
42.86
43.09
43.47
43.84
44.07
44.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Doximity (DOCS) Moving Averages

Oct 13, 2024, 10:46 AM
Period
Simple
Exponential
MA5
43.64Sell
43.52Sell
MA10
43.57Sell
43.25Buy
MA20
42.35Buy
42.06Buy
MA50
37.73Buy
38.39Buy
MA100
32.91Buy
34.64Buy
MA200
30.06Buy
31.20Buy
Doximity’s (DOCS) 10-Day exponential moving average is 43.25, while Doximity’s (DOCS) share price is $43.31, making it a Buy.
Doximity’s (DOCS) 100-Day exponential moving average is 34.64, while Doximity’s (DOCS) share price is $43.31, making it a Buy.
Doximity’s (DOCS) stock price is $43.31 and Doximity’s (DOCS) 50-day simple moving average is 37.73, creating a Buy signal.
Doximity’s (DOCS) stock price is $43.31 and Doximity’s (DOCS) 100-day simple moving average is 32.91, creating a Buy signal.
Doximity’s (DOCS) stock price is $43.31 and Doximity’s (DOCS) 200-day simple moving average is 30.06, creating a Buy signal.

Doximity (DOCS) Technical Indicators

Oct 13, 2024, 10:46 AM
Name
Value
Implied Action
RSI (14)
67.14
Neutral
STOCH (9,6)
46.29
Neutral
STOCHRSI (14)
67.22
Neutral
MACD (12,26)
1.78
Buy
ADX (14)
57.24
Sell
Williams %R
-44.23
Buy
CCI (14)
55.88
Neutral
ATR (14)
1.03
-
Ultimate Oscillator
43.88
Neutral
ROC
4.36
Buy
Doximity’s (DOCS) Relative Strength Index (RSI) is 67.14, creating a Neutral signal.
Doximity’s (DOCS) Trend Strength Indicator (ADX) is 57.24, creating a Sell signal.
Doximity’s (DOCS) Commodity Channel Index (CCI) is 55.88, creating a Neutral signal.
Doximity’s (DOCS) Price Rate of Change (ROC) is 4.36, creating a Buy signal.

FAQ

Is DOCS a Buy, Hold, or Sell?
Based on DOCS’s technical indicators, DOCS is a Buy.
    What is DOCS’s RSI (14)?
    DOCS’s RSI (14) is 67.14, which suggests DOCS is a Neutral.
      What is DOCS’s MACD?
      DOCS’s MACD is 1.78, which suggests DOCS is a Buy.
        What is DOCS’s 5-day moving average?
        DOCS’s 5-day moving average is 43.64, which suggests DOCS is a Sell.
          What is DOCS’s 20-day moving average?
          DOCS 20-day moving average is 42.35, which suggests DOCS is a Buy.
            What is DOCS’s 50-day moving average?
            DOCS’s 50-day moving average is 37.73, which suggests DOCS is a Buy.
              What is DOCS’s 200-day moving average?
              DOCS’s 200-day moving average is 30.06, which suggests DOCS is a Buy.
                What is DOCS’s Williams % R (14)?
                DOCS’s Williams % R (14) is -44.23, which suggests DOCS is a Buy.
                  What is DOCS’s CCI (14)?
                  DOCS’s CCI (14) is 55.88, which suggests DOCS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis